Is aliskiren still sold in 2025?
Yes. Aliskiren (brand examples include Tekturna and related country-specific brands) is still available in some markets in 2025, but availability varies by country due to regulatory actions, prescribing restrictions, and local commercial decisions.
Why might aliskiren be harder to find now?
Aliskiren’s availability has been affected by major safety and effectiveness concerns that led regulators to restrict its use—especially for people with diabetes, and in combination with certain other kidney/heart medications. Those limits can reduce demand and lead to lower distribution and discontinuations in some regions.
Is aliskiren approved for patients with diabetes?
In many jurisdictions, aliskiren is restricted or not recommended for patients with diabetes, and the key safety issue is its use in combinations that can worsen kidney outcomes in that group. As a result, even if the drug is still on shelves, it may be uncommon in prescriptions.
Can I still get it if my country had restrictions?
Possibly, but it depends on local rules and whether your country’s product listings include aliskiren. In practice, patients may be switched to alternative blood pressure or kidney-protecting therapies (such as ACE inhibitors or ARBs) when aliskiren is not preferred.
Where to check if it’s available where you live
The fastest way is to check your country’s drug listings or pharmacy inventory systems. If you share your country (or whether you mean the US, UK, EU, India, etc.), I can narrow the answer to what’s known for that specific market.
Sources:
[1] https://www.drugpatentwatch.com/